search URL:,https://patents.google.com/?assignee=ULTRAGENYX+PHARMACEUTICAL+INC
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
US-9511015-B2,Methods and formulations for treating sialic acid deficiencies ,Ultragenyx Pharmaceutical Inc.,Emil Kakkis,2010-07-13,2011-07-13,2016-12-06,2016-12-06,https://patents.google.com/patent/US9511015B2/en,https://patentimages.storage.googleapis.com/e6/66/f0/638d6d89590eee/US09511015-20161206-D00001.png
US-9221858-B2,Sialic acid analogs ,Ultragenyx Pharmaceutical Inc.,"Emil Kakkis, Steven Jungles, He Zhao",2011-10-24,2014-08-15,2015-12-29,2015-12-29,https://patents.google.com/patent/US9221858B2/en,https://patentimages.storage.googleapis.com/3c/51/e0/34187661b385d4/US09221858-20151229-D00001.png
AU-2013209610-B2,Methods and formulations for treating sialic acid deficiencies ,Ultragenyx Pharmaceutical Inc.,Emil D. Kakkis,2012-01-18,2013-01-18,2017-11-30,2017-11-30,https://patents.google.com/patent/AU2013209610B2/en,
US-9241896-B2,Methods and formulations for treating sialic acid deficiencies ,Ultragenyx Pharmaceutical Inc.,Emil Kakkis,2008-12-19,2012-10-24,2016-01-26,2016-01-26,https://patents.google.com/patent/US9241896B2/en,https://patentimages.storage.googleapis.com/6a/13/0c/a04f045593d848/US09241896-20160126-D00001.png
US-2012276560-A1,Biomarkers for assessing sialic acid deficiencies ,"Kakkis Emil D, Darvish Daniel K, Yadira Valles-Ayoub","Emil D. Kakkis, Daniel K. Darvish, Yadira Valles-Ayoub",2010-12-17,2011-12-16,2012-11-01,,https://patents.google.com/patent/US20120276560A1/en,https://patentimages.storage.googleapis.com/0c/cb/08/f5bb34d35d2533/US20120276560A1-20121101-D00001.png
US-9937243-B2,Sialylated glycoprotein compositions and uses thereof ,Ultrageny x Pharmaceutical Inc.,"Steven Jungles, Gabrielle Morris, Jeff Grubb, Michael Vellard, Emil D. Kakkis",2014-03-05,2017-05-26,2018-04-10,2018-04-10,https://patents.google.com/patent/US9937243B2/en,https://patentimages.storage.googleapis.com/75/25/5f/ee3fd5a16e3710/US09937243-20180410-D00001.png
US-2017073366-A1,Crystal forms of sialic acid or salt or solvate thereof ,Ultragenyx Pharmaceutical Inc.,"John KLOPP, Hayley REECE, Jean-Baptiste Arlin, Corinna Marie Reisinger-Becker, Fabrice Dufour",2015-09-14,2016-09-14,2017-03-16,,https://patents.google.com/patent/US20170073366A1/en,https://patentimages.storage.googleapis.com/8d/d9/8b/87490b5f18d9e0/US20170073366A1-20170316-D00000.png
US-2014094505-A1,Biomarkers for assessing treatment of sialic acid deficiency diseases and conditions ,Ultragenyx Pharmaceutical Inc.,"Yiumo CHAN, Steve Jungles, Emil Kakkis",2012-09-21,2013-09-20,2014-04-03,,https://patents.google.com/patent/US20140094505A1/en,https://patentimages.storage.googleapis.com/ac/2e/48/ae84e1d672d936/US20140094505A1-20140403-D00001.png
US-2016296491-A1,Compositions and methods for treatment of movement disorders ,Inserm (Institut National De La Sante Et De La Recherche Medicale),Fanny Mochel,2015-04-07,2016-04-07,2016-10-13,,https://patents.google.com/patent/US20160296491A1/en,https://patentimages.storage.googleapis.com/8b/cc/38/9949b39ea1c62c/US20160296491A1-20161013-D00001.png
US-2015353633-A1,Effective and efficient control of serum phosphate for optimal bone formation ,"Ultragenyx Pharmaceutical Inc., Kyowa Hakko Kirin Co., Ltd.","Emil D. Kakkis, Javier San Martin, Tomohiro SUDO",2014-06-09,2015-05-29,2015-12-10,,https://patents.google.com/patent/US20150353633A1/en,https://patentimages.storage.googleapis.com/9f/32/a2/9b4f2970af01fd/US20150353633A1-20151210-D00001.png
US-2017119861-A1,Methods and compositions for the treatment of amyloidosis ,Ultragenyx Pharmaceutical Inc.,"Emil D. Kakkis, Michel Claude Vellard, Andrzej Swistowski",2015-10-30,2016-10-28,2017-05-04,,https://patents.google.com/patent/US20170119861A1/en,https://patentimages.storage.googleapis.com/bf/00/2a/9f0addab9dbc80/US20170119861A1-20170504-D00001.png
US-2016243071-A1,Solid compositions of triglycerides and uses thereof ,"John KLOPP, Gabrielle Morris, Emil Kakkis, Ultragenyx Pharmaceutical Inc.","John KLOPP, Gabrielle Morris, Emil Kakkis, Steven Jungles",2013-11-14,2014-11-14,2016-08-25,,https://patents.google.com/patent/US20160243071A1/en,https://patentimages.storage.googleapis.com/a1/2e/5e/9e16f2e0b00779/US20160243071A1-20160825-D00001.png
AU-2015227137-B2,Sialylated glycoprotein compositions and uses thereof ,Ultragenyx Pharmaceutical Inc.,"Jeff GRUBB, Steven Jungles, Emil D. Kakkis, Gabrielle MORRIS, Michael VELLARD",2014-03-05,2015-03-05,2019-06-06,2019-06-06,https://patents.google.com/patent/AU2015227137B2/en,
EP-3065726-A1,Creatine analogs and the use thereof ,Ultragenyx Pharmaceutical Inc.,"Steven Jungles, Yiumo CHAN, Emil Kakkis",2013-11-05,2014-11-05,2016-09-14,,https://patents.google.com/patent/EP3065726A1/en,
TW-201629011-A,"Creatine prodrugs, compositions and methods of use thereof ","Farmington Pharma Dev, Ultragenyx Pharmaceutical Inc",William F Brubaker,2014-12-22,2015-12-22,2016-08-16,,https://patents.google.com/patent/TW201629011A/en,
AR-099686-A1,Sialylated glycoproteins compositions and uses of these ,Ultragenyx Pharmaceutical Inc,"Jungles Steven, Grubb Jeff, Morris Gabrielle, Vellard Michael, Kakkis Emil",2014-03-05,2015-03-05,2016-08-10,,https://patents.google.com/patent/AR099686A1/en,
WO-2018222925-A1,Therapeutics for phenylketonuria ,Ultragenyx Pharmaceutical Inc.,"Kiyoshi Tachikawa, Carlos Gustavo PEREZ-GARCIA, Padmanabh Chivukula, Hari Prakash BHASKARAN, Christian W. COBAUGH, Sean Christopher DAUGHERTY",2017-05-31,2018-05-31,2018-12-06,,https://patents.google.com/patent/WO2018222925A1/en,
WO-2018222926-A1,Therapeutics for glycogen storage disease type iii ,Ultragenyx Pharmaceutical Inc.,"Kiyoshi Tachikawa, Carlos Gustavo PEREZ-GARCIA, Padmanabh Chivukula, Hari Prakash BHASKARAN, Christian W. COBAUGH, Sean Christopher DAUGHERTY",2017-05-31,2018-05-31,2018-12-06,,https://patents.google.com/patent/WO2018222926A1/en,
